Jiansong Ji

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang et al. · Signal Transduction and Targeted Therapy · 2023 · 262 citations · Full text

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

Yunbin Zhang, Jingjing Song, Zhongwei Zhao et al. · Cancer Letters · 2019 · 239 citations

Tumor Heterogeneity, Medicine, Immune Microenvironment Heterogenicity +11

Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial

Hai‐Dong Zhu, Jin‐He Guo, Aiwu Mao et al. · The Lancet Oncology · 2014 · 151 citations

Surgical Oncology, Esophageal Cancer, Medicine +8

Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival

Jianfei Tu, Yahui Ding, Xihui Ying et al. · Scientific Reports · 2016 · 133 citations · Full text

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE

Chunli Kong, Zhongwei Zhao, Weiyue Chen et al. · European Radiology · 2021 · 129 citations · Full text